F ine particulate matter (PM) air pollution <2.5 µm in aerodynamic diameter (PM 2.5 ) ranks among the leading risk factors for global morbidity and mortality. 1 Numerous studies demonstrate that short-term exposures over a few days can trigger acute cardiovascular events (eg, myocardial infarctions, 2,3 strokes 4 ). Perhaps even more important from a public health standpoint is that living in highly polluted regions increases cardiovascular morbidity and mortality several fold more than the risk conveyed by brief exposures. 5, 6 One plausible explanation may be that long-term exposures to PM 2.5 can potentiate the development of chronic disease states, thereby synergistically heightening future cardiovascular risk. 7 In this regard, we and others have shown that the inhalation of air pollutants may promote the development of cardiometabolic disorders, including hypertension and type 2 diabetes mellitus (DM). [8] [9] [10] [11] [12] [13] [14] Indeed, a growing number of animal and human experiments add support for the mechanistic plausibility of these associations. [15] [16] [17] [18] [19] Recent estimates suggest that more than three-quarters of the world's population live in regions exceeding the World Health Organization (WHO) annual air quality standards for PM 2.5 (>10 µg/m 3 ). 1, 20 Coincident with burgeoning air pollution levels, rapid urbanization in these societies has led to a coepidemic of the cardiometabolic syndrome. In fact, the majority of cardiovascular deaths, as well as the largest portion of the world's population having hypertension and DM, resides among these same highly polluted countries, posing a threat to global health. 1, [21] [22] [23] Abstract-Mounting evidence supports that fine particulate matter adversely affects cardiometabolic diseases particularly in susceptible individuals; however, health effects induced by the extreme concentrations within megacities in Asia are not well described. We enrolled 65 nonsmoking adults with metabolic syndrome and insulin resistance in the Beijing metropolitan area into a panel study of 4 repeated visits across 4 seasons since 2012. Daily ambient fine particulate matter and personal black carbon levels ranged from 9.0 to 552.5 µg/m 3 and 0.2 to 24.5 µg/m 3 , respectively, with extreme levels observed during January 2013. Cumulative fine particulate matter exposure windows across the prior 1 to 7 days were significantly associated with systolic blood pressure elevations ranging from 2.0 (95% confidence interval, 0.3-3.7) to 2.7 (0.6-4.8) mm Hg per SD increase (67.2 µg/m 3 ), whereas cumulative black carbon exposure during the previous 2 to 5 days were significantly associated with ranges in elevations in diastolic blood pressure from 1. Most of the studies on exposure response relationships of air pollution and cardiovascular morbidity and mortality or surrogates have mostly come from the Western hemisphere, where the levels are significantly lower. 24 Given the fact that the shape of the concentration response relationship suggests attenuation of effects at high doses, it is important to investigate the impact of air pollution at high levels. Our main goal in the Air Pollution and Cardiometabolic Disease (AIRCMD-China) study was to investigate whether the extraordinary high levels of particulate pollutants encountered within a typical Chinese global megacity (ie, population >10 million residents) adversely affect blood pressure (BP) and insulin sensitivity. 14, 25 In our initial report, we found that brief personal-level black carbon (BC) exposures, a metric of combustion-related PM, were associated with rapid elevations (within 6-10 hours) in both BP and heart rate. 14 Here, we present the main study results about the associations of subacute (prior 1-7 days) BC and PM 2.5 exposures measured at the personal and ambient level with changes in hemodynamics and insulin sensitivity among at-risk individuals with the metabolic syndrome.
Methods
Full details about the protocol have been previously published. 14, 25 Briefly, AIRCMD-China was a prospective study investigating the associations between exposure to particulate air pollutants and cardiometabolic responses among participants with the metabolic syndrome, conducted from February 14, 2012 until July 4, 2013. Metabolic syndrome was defined by International Diabetes Federation criteria specific for Asians. 25 The primary outcomes were changes in resting BP levels and metabolic insulin sensitivity determined by the homeostasis model assessment of insulin resistance (HOMA-IR). The study population was composed of nonsmoking adults residing in the Beijing area recruited from clinics affiliated with Peking Union Medical College (PUMC) Hospital and followed up to complete 4 study visit periods during separate seasons within a 1-year time frame. The institutional review board at PUMC Hospital approved the protocol, and all subjects gave written informed consent.
Health Outcomes
Demographic characteristics, medical history, anthropometrics, and self-reported dietary intake and physical activity were collected at the screening visit. During each of the 4 study visit periods, participants performed personal-level BC exposure monitoring for 5 consecutive days before the measurement of health responses. The study outcomes were performed fasting in the morning of each visit day and have been described in detail previously. 14, 25 Heart rate variability was performed using the SpaceLabs EVO digital Holter system (SpaceLabs Healthcare, WA). Aortic augmentation and carotidfemoral pulse wave velocity were determined by SphygmoCor CP device (AtCor Medical, Austrlia), and reactive hyperemial index was determined using peripheral arterial tonometry (EndoPAT2000, Itamar Medical, Israel). Supine BP was measured using the Omron HEM 907XL device. Fasting venous blood samples for plasma glucose, plasma insulin, lipoproteins, glycohemoglobin, adiponectin, and leptin were measured at PUMC. HOMA-IR was calculated using fasting insulin and glucose measures. Concomitant with day 4 of personal BC, 24-hour ambulatory BP levels were determined and reported previously. 14, 25 
Exposure Measurements and Meteorologic Variables
Ambient PM 2.5 levels were obtained from 3 locations in Beijing: US Embassy in Beijing situated in the northeast 3rd Ring Road with PM 2.5 readings posted on a Twitter feed; the Institute of Atmospheric Physics near the north 2nd Ring Road using a tapered element oscillating microbalance sampler until April 30, 2013;  and Tsinghua University at northwest Beijing (between the 4th and 5th Ring Roads) with PM 2.5 measured from tapered element oscillating microbalance sampler since June 15, 2012. The data collected at the US Embassy were the most complete and were thus used for evaluating the associations with study outcomes.
To assess personal exposures to BC, we used a microaethalometer (AethLabs MicroAeth AE51). Subjects carried the AE51 with them throughout their daily activities or placed them nearby when indoors (eg, when sleeping) to measure personal mass concentration of BC every 5 minutes throughout the 5-day period before the clinic visit. To characterize the component of BC exposure related to the overall ambient conditions in the city, 5-minute city center ambient BC concentrations were measured from a second story window located at the Peking Union Medical College Hospital using a dual wavelength aethalometer (Aethalometer AE20; Magee Scientific, CA). This instrument started operation in May 28, 2012, and thus these data were not available for the first season of subject visits. Meteorologic information on daily temperature and relative humidity at a fixed monitoring station close to PUMC Hospital was obtained from the Weather Underground Website.
Statistical Analysis
Descriptive statistics of demographic characteristics were computed for all subjects. Comparisons of functional end points across 4 repeated visits were performed by repeated measures ANOVA, with degrees of freedom 3 and a compound symmetry covariance structure for random effect.
The mean concentrations of ambient exposure during the preceding 1 to 7 days before the measurement of health responses at each visit were computed because most associations with study outcomes were observed during this time period. Similarly, personal-level BC concentrations were averaged at the preceding 1 to 5 days for each subject. The levels of exposure variables 1 day before each study visit are reported, whereas distributions of longer lagging days are not shown because of similar patterns. Transformation of exposure variables was not applied because normal distributions were observed approximately.
To examine associations between exposure variables and outcomes across 4 visits, we used linear mixed models with a random intercept for each subject to account for within-subject correlations because of repeated measurements. In our models, the outcomes of interest include resting BP, HOMA-IR, heart rate variability, pulse wave velocity and pulse wave analysis, endothelial function index, and blood biomarkers. We investigated exposure windows during the preceding 1 to 7 days (1-to 7-day lags) before the measurement of health responses for BC and PM 2.5 . Effects of cumulative exposure ranging from 1 to 7 days before the clinic visit (1-to 7-day averages) on health outcomes were also assessed. All models were adjusted for age, sex, body mass index, hypertension (yes/no), temperature, relative humidity, and visits (categorical), which were selected based on prior knowledge and bivariate association analyses with the outcome. Linear terms of temperature and relative humidity were found to be adequate by the Akaike Information Criterion. All models were evaluated for outliers and influential observations by residual diagnostics. Estimated effects on health outcomes were presented with each SD increase in 1-day lag of personal BC or ambient PM 2.5 .
All analyses were performed with statistical package R version 3.1.2 (www.r-project.org). Statistical significance was assessed using a 2-sided Wald test at the significance level of 0.05.
Results
The majority of patients were overweight (mean body mass index of 26.0), with a history of hypertension (83%). Mean age of the population was 61±9 years with females predominating. Forty eight percent of the participants had previously lived with a smoker for at least 6 months. The baseline hemoglobin A1c in the participants was 6.09 (0.92) suggested prediabetic by guest on July 12, 2017 http://hyper.ahajournals.org/ Downloaded from state in the participants with no trend toward deterioration in glycemic control over 12 months. Table 1 shows the results for all health outcomes measured at each of the 4 study visits. Four participants dropped out (2 after their first visits, 2 after their third visits), and 3 subjects intermittently missed 1 or 2 visits, leaving a total of 248 measurements for each study end point. Mean ambulatory and clinic BP levels were within the prehypertensive range.
Air pollution levels during the study are presented in Table 2 . Both personal and stationary ambient measures of BC exposures were extremely high. The correlation between personal BC and ambient BC was high with a correlation coefficient of 0.88 (Table S1 in the online-only Data Supplement). Correlation of PM 2.5 between sites were strong (r>0.90; P<0.0001). Personal BC correlated significantly with PM 2.5 measurements at all sites but particularly with the US Embassy site (r=0.80; P<0.0001). All of these temporal correlations among measurements taken in different locations indicate that a large component of the day-to-day variations in exposure among our study subjects is common and is strongly influenced by variation in large-scale emission patterns and atmospheric conditions (eg, meteorology). By chance, the study period encompassed a highly publicized air pollution excursion that occurred in January to Results are presented as mean (SD). DBP indicates diastolic blood pressure; HF, high frequency peak; HOMA-IR, homeostasis model assessment of insulin resistance; HR, heart rate; LF, low frequency peak; pNN50, proportion of N-N intervals >50 ms; rMSSD, root mean square of successive differences between N-N intervals; SBP, systolic blood pressure; and SDNN, SD of N-N intervals.
*P value shows significance of differences between 4 visits using repeated measures ANOVA, with 3 degrees of freedom and a compound symmetry covariance structure for random effect.
†All heart rate variability indices are summarized on the log scale.
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February 2013 in Eastern China. 26 These extreme levels of air pollution (eg, maximum of 552.2 μg/m 3 in Beijing and strongly elevated levels of BC; Figure S1 ) were captured by our measurements. Interestingly, 15 subjects were participating in their third observation period during this time, and thus, we additionally focused on their responses to assess potential health impacts. The effects of air pollution exposures on BP are shown in Figures 1 and 2 . Significant associations with ambient BC and elevated systolic and diastolic BP, personal-level BC and diastolic BP, and ambient PM 2.5 with elevated systolic and diastolic BP and augmentation index at heart rate of 75 bpm (AIx.75) were observed at several different single lag day periods of exposures ( Figure 1 ). The most consistent associations were for cumulative PM 2.5 exposure windows across the prior 1 to 7 days with resting systolic BP. The increase ranged from 2.0 (95% confidence interval [CI], 0.3-3.7) to 2.7 (95% CI, 0.6-4.8) mm Hg per SD increase in PM 2.5 (67.2 µg/m 3 ; Figure 2 ). Cumulative personal BC exposures during the previous 2 to 5 days corresponded with elevations in diastolic BP, ranging from 1.3 (95% CI, 0.0-2.5) to 1.7 (95% CI, 0.3-3.2) mm Hg per SD increase (3.6 µg/m 3 ). No PM 2.5 or BC exposure metrics were associated with changes in heart rate (Figures 1  and 2 ), reactive hyperemial index or pulse wave velocity (data not shown).
The effects of air pollution exposures on blood metabolic biomarkers are shown in Figure 3 and in the online-only Data Supplement ( Figure S2 ). Insulin sensitivity was worsened by air pollutants; albeit in a somewhat delayed fashion. Both personal-level BC and ambient PM 2.5 were significantly associated with increases in HOMA-IR (0.18 [95% CI, 0.01-0.36] and 0.22 U [95% CI, 0.04-0.39] per SD increase of personallevel BC and 0.18 [95% CI, 0.02-0.34] and 0.22 U [95% CI, 0.08-0.36] per SD increase of ambient PM 2.5 on individual lag days 4 and 5; Figure 3 ). Because of the null associations during early individual lag days, cumulative exposure windows were not related to HOMA-IR ( Figure S2 ). Finally, changes in leptin and adiponectin (Figure 3 ; Figure S2 ) and multiple heart rate variability metrics ( Figures S3 and S4) were not consistently associated with air pollution exposures.
By chance, the study period encompassed a highly publicized air pollution excursion that occurred in January to 26 This period of extreme air pollution (eg, maximum of 552.2 μg/m 3 in Beijing and strongly elevated levels of BC; Figure S1 ) was captured when 15 subjects were participating in their third observation period, and thus, we additionally analyzed their responses. Table S2 presents the changes in low-frequency peak and SD of N-N intervals and demonstrates a decrease in SD of N-N intervals and low-frequency peak in these subjects during this period.
Discussion
Our findings demonstrate an impact of short-term variation in high levels of ambient air pollution metrics on health outcomes in Beijing, China. 27 We show that both PM 2.5 and BC are linked to increases in BP and insulin resistance, even among at-risk individuals who have been living for long periods in these conditions. This observation supports our hypothesis that the rising twin epidemics of cardiometabolic diseases 21, 22 and poor air quality 20 among developing regions may be more than a simple coincidence arising from the common soil of urban lifestyles.
We recently demonstrated that personal-level exposure to BC in Beijing (a marker of traffic-related pollutants) increases BP and heart rate within a few hours. 14 These main results from the AIRCMD-China study confirm and extend our previous observations by showing that city-wide ambient levels of PM 2.5 and BC (as well as BC measured at the personal-level) over the prior 1 to 7 days are linked to higher BP levels and insulin resistance. Although air pollutants have also been associated with a risk of developing DM, 8, 10, 11 few studies have evaluated effects on glucose metabolism or insulin sensitivity in humans. [28] [29] [30] [31] [32] [33] This current study is the first to be performed at such high levels among individuals with the metabolic syndrome over multiple seasons. It is important to note that the observed effects (ie, increased BP and insulin resistance) occurred among at-risk individuals within the context of acute elevation in air pollution levels on top of continuing chronic exposures and still remain capable of provoking biological responses linked to risk of developing hypertension and DM. Under conditions of extremely high levels of air pollution, there is the potential of alteration of parasympathetic tone that may also be important as demonstrated in a subset of 15 patients, who underwent biological measurements during a period of extremely high levels of air pollution. Particulate air pollutants have been postulated to trigger elevation in BP and worsen insulin resistance via several pathways. 7, 8, 16, 18, 28 Despite a sound mechanistic basis that air pollutants could provoke adverse cardiometabolic responses, such as increase in circulating cytokines and inflammation, neither PM 2.5 nor BC were related to these outcomes in this study. Microvascular endothelial dysfunction (ie, lower reactive hyperemial index) and impaired arterial compliance (ie, higher pulse wave velocity) are also unlikely explanations for BP elevation given their lack of association. It is possible that chronic high degrees of exposure as was the case with this study may have slightly different underlying mechanisms. PM 2.5 , hypertension, and DM are each independent major risk factors for global morbidity and mortality. 1 Even low levels of PM 2.5 are linked to excess cardiovascular events, suggesting that there are no known safe lower thresholds at the population level. 5, 7 Similarly, small elevations in BP and plasma glucose (eg, prehypertension and pre-DM) over the long-term are both causally related to adverse cardiovascular health outcomes. 34,35 Therefore, even modest perturbations in BP and metabolic control could be linked to significant public health burden given the billions of people affected by air pollution globally and continually. 
Resting HR
AIx.75 Figure 2 . Changes in Seated clinic blood pressure levels associated with previous 1-to 7-day long cumulative particulate matter (PM) air pollution <2.5 µm in aerodynamic diameter (PM 2.5 ) and black carbon (BC) concentrations. AIx.75 indicates augmentation index at a heart rate of 75 bpm; DBP, diastolic blood pressure; HR, heart rate; and SBP, systolic blood pressure. Data points and error bars represent the estimated changes of the health end points and 95% confidence intervals associated with a 3.61 μg/m 3 increase in 1-to 7-day long cumulative personal and ambient BC concentrations and a 67.2 μg/m 3 increase in 1-to 7-day long cumulative ambient PM 2.5 concentrations using linear mixed models. Significant associations (P value≤0.05) were shown in red. All models controlled for age, sex, body mass index, temperature, relative humidity, hypertension, diabetes mellitus, and study visit. by guest on July 12, 2017 http://hyper.ahajournals.org/
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The strengths of the study include repeated assessments of biologically relevant measures over 12 months in the same individual and performance of the study at a time of unprecedented levels of air pollution levels. Furthermore, the performance in an at-risk patient population renders the findings of our study all the more important. We acknowledge multiple limitations, including lack of specific PM characterization that may have allowed better delineation of constituents driving the relationships in this study. We also do not have detailed characterization of insulin responses assessed using clamp measures. Given the nature of the design (4 seasons), this may have been hard to accomplish. Finally, it is possible that other environmental determinants that cosegregate with air pollution may have contributed to these effects, and it is impossible to definitively rule out the contribution of these factors.
Perspectives
Worldwide data support that most cardiovascular events, as well as the highest prevalence of cardiometabolic conditions, are among developing nations. 21, 22 Our findings provide evidence for an influential role of air pollution in cardiometabolic health, even at extremely high concentrations faced by billions of people in the developing world today. We recognize that many other factors must also be important (eg, obesity, diet, exercise) as hypertension and DM rates are increasing in North America despite falling PM 2.5 levels. [20] [21] [22] Nonetheless, even low levels of air pollution have been associated with an excess of cardiometabolic disorders. [10] [11] [12] As such, we think that more studies are urgently needed to confirm this hypothesis of potential worldwide public health importance. What Is New?
• We have evaluated the effects of air pollutants on cardiometabolic outcomes in subjects with metabolic syndrome living in a highly polluted megacity in Asia.
• Both personal and city-wide ambient levels of black carbon (as well as PM 2.5 measured at ambient level) over the prior 1 to 5 days are linked to higher blood pressure levels and insulin resistance.
• In our study, a subset of subjects underwent measurements during the severe air pollution haze event over Eastern China in January 2013 (PM 2.5 >500 mg/m 3 ).
What Is Relevant?
• The association between personal-level exposure to black carbon and elevation in blood pressure within a few hours was found in our previous observation. The longitudinal analysis on the subacute exposure confirmed and extended the relationships between air pollutants and cardiometabolic outcomes. The consistency of our findings across seasons, a range of doses, and study designs render our work much more relevant.
Summary
Our results suggest subacute exposures to particulate air pollutants are associated with adverse changes in blood pressure and insulin sensitivity among at-risk individuals living in a region chronically suffering from very high ambient levels. Associations between paired pollutants were tested using Pearson's correlation coefficients, pvalues < 0.0001. 
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